StonvexLoading…
StonvexStonvexStonvexCore line items from EVCM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $588.91M | $562.18M | $534.87M | $620.75M |
Operating Income | $59.25M | $26.20M | $-2.92M | $-30.59M |
Net Income | $17.60M | $-41.09M | $-45.62M | $-59.82M |
EPS (Diluted) | $0.10 | $-0.22 | $-0.24 | $-0.31 |
Total Assets | $1.37B | $1.42B | $1.52B | $1.59B |
Total Liabilities | $654.92M | $670.44M | $692.03M | $685.03M |
Cash & Equivalents | $129.73M | $135.78M | $92.61M | $92.63M |
Free Cash Flow OCF − CapEx | $109.23M | $111.70M | $101.57M | $62.24M |
Shares Outstanding | 178.11M | 183.73M | 186.93M | 191.45M |